Stryker Corp
Health Care
Stryker Corp (SYK) Stock News
The latest SYK headlines and market coverage — 2 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK
Pomerantz LLP is investigating Stryker Corp. for potential securities fraud following the CEO's disclosure on September 8, 2026, that a manufacturing problem in the peripheral vascular business would persist into Q4 2026 instead of resolving in Q3 as previously stated. The announcement triggered an 8.81% stock price decline, falling $26.70 per share to $276.43.
- Zacks Investment Research·
GEHC or SYK: Which Is the Better Value Stock Right Now?
In a comparison of two Medical-Products sector stocks, GE HealthCare Technologies (GEHC) emerges as the superior value option for value investors. GEHC has a Zacks Rank of #2 (Buy) with improving earnings outlook, a lower forward P/E of 12.98 versus Stryker's 18.76, and a Value grade of A compared to Stryker's C grade. Key valuation metrics favor GEHC, including a lower PEG ratio (1.69 vs 1.76) and P/B ratio (2.63 vs 4.5).